Log in to save to my catalogue

Successful outcome in a compound heterozygote haemoglobin E/beta-thalassaemia in pregnancy

Successful outcome in a compound heterozygote haemoglobin E/beta-thalassaemia in pregnancy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9906172

Successful outcome in a compound heterozygote haemoglobin E/beta-thalassaemia in pregnancy

About this item

Full title

Successful outcome in a compound heterozygote haemoglobin E/beta-thalassaemia in pregnancy

Publisher

England: BMJ Publishing Group LTD

Journal title

BMJ case reports, 2023-02, Vol.16 (2), p.e252829

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

Haemoglobin E (HbE) affects at least 1 million people around the world. The carrier frequency of HbE/beta-thalassaemia (HbE/β-thalassaemia) is highest in Southeast Asia. In India, the highest frequency is observed in the northeast region. Distinguishing between homozygous HbE disease and HbE/β-thalassaemia is a challenge to the haematopathologist a...

Alternative Titles

Full title

Successful outcome in a compound heterozygote haemoglobin E/beta-thalassaemia in pregnancy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9906172

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9906172

Other Identifiers

ISSN

1757-790X

E-ISSN

1757-790X

DOI

10.1136/bcr-2022-252829

How to access this item